The BFRF1 protein of Epstein -Barr virus (EBV) is a recently identified membrane protein that is the homolog of the alphaherpesvirus UL34 gene product. We report here that a yeast two-hybrid screen identified the BFLF2 gene product, a homolog of alphaherpesvirus UL31, as a protein that interacts with BFRF1. Expression of BFLF2 in mammalian cells revealed a protein of approximately 28 kDa that associated with BFRF1 in a noncovalently linked complex. When expressed alone, the BFRF1 protein was found in the cytoplasm and perinuclear region. BFLF2 was found diffusely in the nucleus in the absence of BFRF1, but coexpression of BFRF1 and BFLF2 resulted in colocalization of the two proteins at the nuclear rim. These data recapitulate the behavior of the alphaherpesvirus homologs of BFRF1 and BFLF2 and suggest that functional as well as structural and positional homology may be conserved.
Introduction
Epstein-Barr virus (EBV) is a gammaherpesvirus that is carried by more than 95% of the adult population worldwide (Henle and Henle, 1979) . Although many people suffer no ill-effects as a result, primary infections can be accompanied by acute infectious mononucleosis and long-term carriage may be associated with both lymphoid and epithelial malignancies. Among these are immunoblastic lymphoma, Burkitt's lymphoma, Hodgkin's disease, nasopharyngeal carcinoma, gastric cancer, and possibly breast cancer (Rickinson and Kieff, 2001) . Each disease, including infectious mononucleosis, involves either a response to or the growth of a cell that is latently infected with EBV. Much of the research into the biology and pathogenesis of EBV has thus appropriately focused on the establishment and consequences of latency. The unintended consequence is that less is known about some of the important lytic cycle proteins of EBV than about those of other herpesviruses, particularly the alphaherpesviruses that more readily undergo lytic replication.
The basic strategy of replication is shared among the herpesviruses and many insights into the potential functions of EBV-encoded proteins have come from knowledge of the functions of proteins of other herpesviruses that appear to have been conserved either in sequence, structure, or genomic organization. However, some apparently well-conserved proteins have proven to mediate surprisingly different functions. For example, the glycoprotein gB of herpes simplex virus (HSV) and other alphaherpesviruses plays an important role in virus entry, but is dispensible for virus assembly and egress (Roizman and Knipe, 2001) . In contrast, while EBV glycoprotein gB is probably required for virus cell fusion (Haan et al., 2001) , it also plays a critical role in capsid formation and virus release (Herrold et al., 1995; Lee and Longnecker, 1997) . Similarly, although the glycoprotein gNgM complex of alphaherpesviruses is not essential for replication, the EBV gNgM shows no redundancy with other virus proteins and its loss significantly impairs formation of enveloped virions (Lake and Hutt-Fletcher, 2000) .
Two newly studied interactive alphaherpesvirus proteins (Fuchs et al., 2002; that are conserved in all the herpesvirus subfamilies are the UL31 and UL34 gene products (Baer et al., 1984; Chee et al., 1990; McGeoch et al., 1988) . Expression of these proteins is required for efficient envelopment of alphaherpesviruses at the nuclear membrane (Chang et al., 1997; Fuchs et al., 2001 Fuchs et al., , 2002 Klupp et al., 2000; Shiba et al., 2000) and the cytomegalovirus (CMV) homologs, which also interact, recruit cellular kinases for phosphorylation and dissolution of the nuclear lamina (Muranyi et al., 2002) . UL34 is predicted to be, and in HSV is, a type II membrane protein (Shiba et al., 2000) , whereas UL31 is not predicted to have any transmembrane domains and in herpes simplex virus is a phosphoprotein that associates with the nuclear matrix (Chang and Roizman, 1993) . The nuclear localization of UL31 family members studied to date is an intrinsic property of the proteins, but association with UL34 influences the distribution of both partners. UL31, when expressed independently, is found throughout the nucleus, but when expressed with UL34 is found at the nuclear rim.
When UL34 is expressed independently, it is found in the nucleus envelope and cytoplasm, whereas in association with UL31 it colocalizes to the nuclear rim (Fuchs et al., 2002; Reynolds et al., 2001) . Farina et al. (2000) recently reported that the BFRF1 gene of EBV encodes a nonglycosylated early or late protein that migrates as a doublet of approximately 37 -38 kDa. The protein was found predominantly on nuclear membranes of virus-producing cells, although some expression was seen in the cytoplasm and on the plasma membrane and was also present in extracellular virions. In view of the studies done with the BFRF1 homologs in other herpesviruses we sought to determine if the EBV protein also interacted with the EBV UL31 homologue BFLF2. We report here that the two proteins form a stable association that, as in the alphaherpesviruses, influences the intracellular localization of each and is compatible with a similar role for the complex in primary virion envelopment. reading BFLF2 open reading frame was amplified from the BamH1 F fragment of EBV DNA with primers P1 and P2 and cloned into pGADT7 in frame with an HA tag (black bar) and the GAL4 activation domain (GAL4 AD) to make pGADT7-HA-BFLF2. HA-tagged BFLF2 was cut from pGADT7-HA-BFLF2 and cloned into pTM1 to make pTM1-HA-BFLF2. (Right side, top) Rightward-reading BFRF1 open reading frame was amplified from BamH1 F with primers P3 and P4, cut with Sma1 to remove the predicted transmembrane domain (hatched bar), and cloned into pAS-2 in frame with the GAL4 DNA-binding domain (GAL4 AD) to make pAS2-1-BFRF1. The BFRF1 open reading frame was also amplified with primers P3 and P5, which contained sequences encoding a Flag epitope (checked bar), and cloned into pTM1 to create pTM1-BFRF1-Flag. The library made from Akata cells induced to produce EBV was recombined into pGADT7-Rec to fuse sequences to GAL4-AD and HA. The numbering of the base pairs refers to the B95-8 sequence.
Results

Interaction of BFRF1 and BFLF2 gene products in yeast two-hybrid analyses
The genomic organization of the BamH1 F fragment is shown in Fig. 1A . The rightward-reading BFRF1 open reading frame is predicted to encode a 336-amino acid protein with a potential transmembrane domain between residues 317 and 333. The expected topology of the protein is that of a type-II membrane protein with a long cytoplasmic tail extending from residues 1 to 317 and an extremely short luminal domain. Because only the cytoplasmic tail might be expected to interact with a nuclear protein such as a homolog of the UL31 protein, the BFRF1 open reading frame, truncated at residue 317, was amplified from the EBV BamH1 F fragment and cloned downstream of the GAL4 DNA-binding domain to make pAS2-1-BFRF1 (Fig. 1B) and rescued into the yeast strain Y187. A cDNA library was constructed in yeast strain AH109 from mRNA isolated from Akata cells in which approximately 60% of the cells had been induced into the EBV lytic cycle. AH109 and Y187 cells were mated to screen for proteins that were interactive with BFRF1. Fifty-one colonies grew out on selective medium indicating that they had simultaneously activated the TRP and LEU genes in the plasmids and also the HIS3 and ADE2 genes under control of the GAL4 promoter. Of these, 28 also activated GAL4-driven MEL1 as judged by secretion of h-galactosidase. Plasmids from eight colonies were rescued into bacteria for sequencing and the three from which sequence was successfully obtained mapped to the BFLF2 open reading frame (two at nt 56 933 -56 762 and one at nt 56 837 -56 778). Although the cDNAs had originally been transcribed with oligo dT primers and contained sequences large enough to contain the entire open reading frame, the interaction was reevaluated by amplifying the fulllength leftward-reading open reading frame, the BamH1 F fragment cloning it into pGADT7, rescuing it into AH109, and remating the new transformant with pAS2-1-BFRF1 in Y187 under selection as described above. Colonies were visible at 5 days whereas the same cells mated with partners containing either of the empty vectors failed to activate expression of HIS3, ADE2, or MEL1.
Interactions between full-length BFRF1 and BFLF2 proteins expressed in mammalian cells
To obtain biochemical confirmation of an interaction between the BFRF1 and BFLF2 proteins, full-length constructs of each were cloned for high-level expression into the pTM1 vector under control of a T7 promoter. A Flag epitope was added to the carboxy terminus of BFRF1 and the BFLF2 protein retained the amino terminal HA tag that had been added when it was cloned into the yeast vector pGADT7. CV1 cells were transfected with combinations of the constructs and concurrently infected with a vaccinia virus expressing the T7 polymerase. A monoclonal antibody to the Flag epitope, but not a monoclonal antibody to the 
Effects of coexpression on the cellular localization of BFRF1 and BFLF2 proteins
In the absence of UL31, the alphaherpesvirus UL34 protein is found in the cytoplasm and perinuclear region; in the absence of UL34, the UL31 protein is found diffusely in the nucleus. To determine if the EBV counterparts of UL34 and UL31 behaved in the same way, CV1 cells were transfected with either construct, stained with the appropriate monoclonal antibody, and counterstained with DAPI to visualize the nuclei. When expressed alone, the BFRF1 protein was found in the cytoplasm and around the nucleus, but was excluded from the nucleus itself as indicated by no overlap of antibody and DAPI staining (Fig. 3) . In contrast, the BFLF2 protein was confined to the nucleus as con- firmed by the white signal generated when photomicrographs of antibody and DAPI staining were merged. To examine the effects of coexpression of BFRF1 and BFLF2 on protein localization, cells were transfected with one or the other or both BFRF2-and BLFL2-expressing plasmids, stained with antibodies to HA, to Flag, or to both, and viewed by confocal microscopy. As before, the BFRF1 protein was cytoplasmic and perinuclear when expressed alone, and the BFLF2 protein was restricted to the nucleus. However, when the proteins were coexpressed, the proteins colocalized to the nuclear rim in approximately 90% of the cells. Staining fully encompassed the nuclear rim, although the staining was slightly punctate. In the minority of cells in which localization to the nuclear rim did not occur, both BFRF1 and BFLF2 staining were seen diffusely in the cytoplasm.
Discussion
The genomic organization of the BFRF1 and BFLF2 genes of EBV is similar to that of the UL34 and UL31 genes of the alphaherpesvirus and the genes are considered to be homologs. The results presented here indicate that the proteins of the two different subfamilies, which are predicted to be similar in structure, also share behavioral traits that are consistent with similar roles in virus replication.
The BFRF1 open reading frame has previously been reported to encode a doublet that migrates with an apparent mass of 37-38 kDa (Farina et al., 2000) . The mass of the doublet reported here, 32-34 kDa, is slightly smaller than this, but given potential differences in electrophoresis conditions is reasonably consistent with the previous report. The BFLF2 open reading frame is predicted, but not known, to express a protein of approximately 35 kDa. The epitope-tagged protein expressed here is approximately 28 kDa. Both the yeast two-hybrid data and the biochemical analyses indicate that like their counterparts in other herpesviruses the BFRF1 and BFLF2 proteins interact. Coprecipitation is possible in the presence of sodium dodecyl sulfate. Coexpression has no effect on the mobility of either protein, but in the presence of BFRF1, the BFLF2 protein appears to be slightly more stable. A similar effect has been reported for the UL34 and UL31 proteins, perhaps more striking because it was studied in the context of HSV replication where UL31 becomes particularly susceptible to proteasomal digestion in the absence of UL34 . The dramatic effects of coexpression on the cellular localization of UL31 and UL34 are also recapitulated for BFRF1 and BFLF2. Expressed in isolation, UL31 and UL34 of HSV colocalize at the nuclear rim in the same punctate pattern as seen here. In virus-infected cells, however, staining is more uniform. Expression of the US3 kinase in addition to UL31 and UL34 is required to reproduce the same even staining pattern in transfected cells. This is consistent with a requirement for phosphorylation of UL34 by US3 because, in its absence, localization of UL34 to the nuclear membrane is also delayed (Reynolds et al., 2001 ). Farina et al. (2000) show photomicrographs in which BFRF1 staining in infected cells also appears to be more uniform that the staining seen here, although detailed comparisons of conventional and confocal microscopy are difficult to evaluate and as yet we have no reagents with which either native BFRF1 or BFLF2 can be visualized in virus-producing cells. EBV encodes no homolog to US3, but the BGLF4 open reading frame encodes a kinase that is a homolog of the human cytomegalovirus UL97 kinase. UL97 is required for efficient nuclear egress of human CMV and UL34 has been suggested to be a potential target for UL97 (Krosky et al., 2003) . Preliminary experiments in which a BGLF4 expression plasmid was cotransfected with BFRF1 and BFLF2 did not show any change in protein distribution and neither BFRF1 nor BFLF2 was phosphorylated in either the presence or absence of BGLF4 (data not shown), but it is also possible that as in murine CMV the punctate pattern of staining is the normal distribution (Muranyi et al., 2002) .
Current models of herpes virus assembly and egress propose that the capsid first acquires an envelope as it buds through the inner nuclear membrane. De-enveloped nucleocapsids are then delivered to the cytoplasm by fusion with the outer nuclear membrane or that of the endoplasmic reticulum with which it is contiguous. The final envelope is acquired by rebudding into a cytoplasmic compartment, probably the trans-Golgi network, that puts the virus back in a later stage of the exocytic pathway (Mettenleiter, 2002) . Alphaherpesviruses UL31 and UL34 have been shown to play a critical role in egress from the nucleus, and enveloped virions in the perinuclear space contain UL34. There are, however, conflicting reports as to the complete distribution of UL34 during virus replication. UL34 has variously been reported as detectable only at the nuclear membrane and in the envelope of virus in the perinuclear space (Fuchs et al., 2002; Klupp et al., 2000; Reynolds et al., 2001 Reynolds et al., , 2002 , which is consistent with a model in which primary and secondary envelopes differ in content as well as site of acquisition, or as present in nuclear membranes and in the extracellular virus (Purves et al., 1992; Shiba et al., 2000) . The latter is consistent with observations suggesting that UL34 interacts with dynein and is important to the intracellular transport of incoming virus . Farina et al. (2000) reported that during virus replication, the BFRF1 protein was not only detected predominantly at the nuclear membrane, but could also be seen at the plasma membrane and in the virus. Expressed as a recombinant protein, we confirm the strong association with the nuclear envelope, but find no evidence for expression of BFRF1 at the plasma membrane, although the distinction between nuclear and plasma membrane is clearer in epithelial cells in which we expressed the protein than it is in the lymphocytes studied previously where the nuclear to cytoplasmic ratio is much higher. It is also possible that expression in the context of virus is different because of interactions with additional virus proteins.
The only evidence pertinent to the envelopment or reenvelopment model of egress for EBV comes from studies of the distribution of EBV gB in the B958 strain of the virus where gB is found predominantly in the membranes of the nucleus and endoplasmic reticulum and mainly carries high mannose sugars, consistent with a lack of processing in the Golgi apparatus, whereas the virus attachment protein gp350/220, which carries large amounts of Golgi-dependent O-linked sugars, is primarily found in the plasma membrane and Golgi. The virion envelope contains copious amounts of gp350/220, but only very small amounts of a differentially glycosylated form of gp110, gp125, that carries some Golgi-modified sugars (Gong and Kieff, 1990) . These data are consistent with the sequential formation of two differently enveloped virions. The strikingly similar behavior of the BFRF1 -BFLF2 complexes and their homologs in herpesviruses that have been more extensively studied suggests that the roles of the UL34 and UL31 proteins in virus egress may be recapitulated in EBV. Generation of a recombinant EBV that is deleted for expression of either BFRF1 or BFLF2 will help determine if these are proteins that functionally similar to their counterparts or have evolved different or additional roles in gammaherpesvirus replication.
Materials and methods
Mammalian and yeast cells
Akata, a Burkitt lymphoma-derived cell line that carries and can be induced to make EBV (Takada and Ono, 1989) , was grown in RPMI 1640 (Sigma, St. Louis, MO) supplemented with 10% heat-inactivated fetal bovine serum (Gibco/BRL, Grand Island, NY). CV-1 monkey kidney cells were grown in Dulbecco's modified Eagle's medium containing 10% heat-inactivated fetal bovine serum. Yeast strain Y187 (BDClontech, Palo Alto, CA) contains the reporters lacZ and MEL1 and the transformation markers trp1 and leu2. Yeast strain AH109 (BDClontech) contains the reporters HIS3, ADE2, lacZ, and MEL1 and the transformation markers trp1 and leu2.
Antibodies
Mouse monoclonal antibodies used were anti-Flag-M2 (Sigma), HA.11 antibody to HA (Covance, Princeton, NJ), and fluorescein-conjugated 12CA5 antibody to HA (Roche Diagnostics, Indianapolis, IN). Secondary antibodies used were goat anti-mouse IgG conjugated to Alexa Fluor 563 (Molecular Probes, Eugene, OR) and fluorescein-conjugated sheep anti-mouse IgG (ICN/Cappel, Irvine, CA).
Plasmids for yeast two-hybrid analysis
The BFLF2 ORF was amplified by a PCR method from the BamH1 F fragment of B95.8 virus DNA (a gift of Clare Sample, St. Jude Children's Research Hospital). The 5V primer P1 (GAT CGA TCA TAT GGC CCC GGT CAC C) included the first ATG of the ORF and an Nde1 site. The 3V primer P2 (GGC GGA TCC CTG TTT ATT TTC C) included a BamH1 site. The DNA amplified with these primers was cut with Nde1 and BamH1 and inserted into pGADT7 that was cut with the same enzymes to make the plasmid pGADT7-BFLF2 in which BFLF2 was in frame with the GAL4 activation domain. The BFRF1 ORF was also amplified by a PCR method from the BamH1 F fragment. The 5V primer P3 (CTG GAA TTC CAT GGC GAG CCC GGA A) included the first ATG of the ORF and both an EcoRI and a NcoI site. The 3V primer P4 (GGC GGA TCC GGT CCA CCT CAG AAA) included a BamH1 site. The DNA amplified with these primers was cut with NcoI and SmaI, which cuts the ORF at nucleotide 894 and removes 114 nucleotides of 3V sequence, and inserted into the pAS2-1 vector (BDClontech) which had previously been cut with the same enzymes to make plasmid pAS2-1-BFRF1.
Yeast two-hybrid library
Akata cells were induced at a concentration of 10 6 cells/ ml with 86 Ag/ml goat antihuman IgG (ICN/Cappel) for 12 h. Cells were pelleted, washed once in phosphate-buffered saline, flash frozen in liquid N 2 , and stored at À85 jC. RNA was extracted from cells using the Totally RNA Isolation Kit (Ambion Inc, Austin, TX). cDNA synthesis and library construction were carried out with the MATCH-MAKER Library Construction and Screening Kit (BDClontech) according to the manufacturer's instructions. In brief, approximately 2 Ag of RNA was used for firststrand synthesis with oligo (dT) primers. cDNA was amplified by PCR [95 jC/30 s, 23Â (95 jC/10 s, 68 jC/ 6 min increasing 5 s with each successive cycle) 68 jC/5 min], purified, and transformed into lithium acetate-competent AH109 cells together with the plasmid pGADT7 Rec and carrier DNA. Transformants were selected on SD/-Leu plates. Freezing media were added to each plate to collect transformants and the library was aliquoted and stored at À85 jC.
Yeast two-hybrid screens pAS2-1-BFRF1 in Y187 was mated with the EBV lytic cell library in pGADT7 following the protocol outlined in the MATCHMAKER Library Construction and Screening Kit. Colonies were grown on quadruple synthetic dropout (SD) medium lacking tryptophan, leucine, histidine, and adenine and screened for h-galactosidase activity in a colony lift filter assay. Plasmids were isolated from yeast cells with the Q Biogene RPM Yeast Plasmid Isolation Kit (Midwest Scientific, St Louis, MO) and rescued in M9 medium lacking leucine into Escherichia coli strain KC8 (BDClontech), which has a defect in leuB that can be complemented by yeast LEU2. Plasmids were then rescued back into strain DH5a for sequencing. cDNA sequences were compared to known DNA and protein sequences using the BLAST network service and sequence analysis software of the National Center for Biotechnology Information. pAS2-1-BFRF1 in Y187 and pGADT7-BFLF2 in AH109 were mated at 30 jC on quadruple dropout agar plates by cross streaking.
Expression in the pTM1 vector
The BFRF1 ORF was amplified from the BamH1 F fragment with the 5' primer P3 (CTG GAA TTC CAT GGC GAG CCC GGA A) that included the first ATG of the ORF and both an EcoRI and an NcoI site and the 3V primer P5 (CCG GAT CCT TAT CGT CGT CGT CCT TGT AAT CGG TCC ACC TCA G) that included a flag tag and a BamH1 site. The DNA amplified with these primers was cut with NcoI and BamH1 and inserted into pTM1 (Moss et al., 1990 ) that had previously been cut with the same enzymes to make plasmid pTM1-BFRF1-Flag. The BFLF2 ORF was cut from pGADT7-BFLF2 with NcoI and BamH1. The ORF, now containing a HA tag in frame at the 5V end, was inserted into pTM1 that had been cut with the same enzymes to make the plasmid pTM1-HA-BFLF2. Plasmids were transfected into CV1 cells 30 min after the cells had been infected with vaccinia virus expression T7 at a multiplicity of 5. For transfections of a single plasmid, 6 Ag of DNA was mixed with 40 Al of Lipofectamine (Gibco/ BRL) made to a total volume of 800 Al with serum-free medium. For transfection of two plasmids, 6 Ag of each was used. Each mixture was incubated for 45 min at room temperature before addition to cells.
Immunofluorescence and confocal microscopy
CV-1 cells that had been infected with vvT7 and transfected with pTM1-BFRF1-Flag, pTM1-HA-BFLF2, or a mixture of plasmids were air-dried on slides and fixed for 10 min in ice-cold acetone. For observation by fluorescence microscopy, cells were incubated sequentially for 30 min at 37 jC with antibody specific for HA or Flag epitopes and fluorescein-conjugated sheep anti-mouse IgG, stained with DAPI at a final concentration of 300 AM for 5 min at 37 jC, and mounted in DABCO. Cells were washed three times in phosphate-buffered saline between each incubation. For confocal laser scan microscopy, cells were incubated sequentially with antibody specific for Flag, goat anti-mouse IgG conjugated to Alexa Fluor 563, and fluorescein-conjugated mouse anti-HA. Fluorescence was viewed with an Olympus BX61 upright epifluorescence microscope coupled to an Olympus Fluoview 300 confocal microscope and images were digitized with the Fluoview program version 4.1.
Radiolabeling and immunoprecipitation
CV-1 cells that had been infected with vvT7 and transfected with pTM1-BFRF1-Flag, pTM1-HA-BFLF2, or a mixture of plasmids were labeled with [ 3 H] leucine as previously described (Lake et al., 1998) . Labeled cells were solubilized in radioimmunoprecipitation buffer (50 mM Tris -HCl, pH 7.2, 0.15 M NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 0.1 mM phenylmethyl-sulfonylfluoride, and 100 U of Aprotinin per ml) and immunoprecipitated with antibody and protein A-Sepharose CL4B (Sigma). Immunoprecipitated proteins were washed, dissociated by boiling for 2 min in sample buffer with 2-mercaptoethanol, and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in 10% polyacrylamide cross-linked with 0.28% N,NV-diallyltartardiamide followed by fluorography.
